Group One Trading’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.03M	Buy	70,300 +16,700	+31%	+$267K	﹤0.01%	2691
2025 Q4	$413K	Sell	53,600 -10,900	-17%	-$86K	﹤0.01%	3707
2025 Q3	$475K	Buy	64,500 +14,400	+29%	+$73.7K	﹤0.01%	3759
2025 Q2	$200K	Sell	50,100 -25,900	-34%	-$94.2K	﹤0.01%	4341
2025 Q1	$242K	Sell	76,000 -15,200	-17%	-$71.6K	﹤0.01%	3822
2024 Q4	$488K	Buy	91,200 +35,400	+63%	+$264K	﹤0.01%	3198
2024 Q3	$295K	Buy	55,800 +29,000	+108%	+$104K	﹤0.01%	3279
2024 Q2	$48.8K	Buy	26,800 +20,000	+294%	+$37.3K	﹤0.01%	4540
2024 Q1	$12.1K	Sell	6,800 -1,400	-17%	-$2.92K	﹤0.01%	5758
2023 Q4	$14.4K	Sell	8,200 -11,000	-57%	-$16.1K	﹤0.01%	5969
2023 Q3	$28K	Sell	19,200 -17,200	-47%	-$36.4K	﹤0.01%	5610
2023 Q2	$83.4K	Buy	36,400 +35,900	+7,180%	+$74.6K	﹤0.01%	4791
2023 Q1	$455	Sell	500 -4,300	-90%	-$3.36K	﹤0.01%	6918
2022 Q4	$4.08K	Sell	4,800 -22,300	-82%	-$19.7K	﹤0.01%	6418
2022 Q3	$22K	Sell	27,100 -17,700	-40%	-$16.9K	﹤0.01%	6000
2022 Q2	$44K	Buy	44,800 +40,300	+896%	+$49.4K	﹤0.01%	5672
2022 Q1	$7K	Sell	4,500 -44,400	-91%	-$81.3K	﹤0.01%	7285
2021 Q4	$118K	Sell	48,900 -228,000	-82%	-$884K	﹤0.01%	5578
2021 Q3	$1.34M	Buy	276,900 +273,700	+8,553%	+$810K	﹤0.01%	3086
2021 Q2	$9K	Buy	3,200 +100	+3%	+$275	﹤0.01%	7552
2021 Q1	$10K	Buy	+3,100	New	+$11.2K	﹤0.01%	7043